Contract Research Organization: Ophthalmology Research - Iris Pharma Iris Pharma, a Contract Research Organization, provides preclinical and clinical research in ophthalmology: ocular safety, efficacy, ocular pharmacokinetics, clinical trials, bioanalytical...

LIEN: OCTALIA_STABILITE_2013_115 0.05%ML7 AND PLACEBO EYE-DROPS CONTAINING 0.3%HPMC (BATCHES E728-1’ AND E728-2’) OR 0.1%HEC (BATCHES E728-3 AND E728-4) 6-MONTH STABILITY REPORT NEUROPTIS Issued date: February 07th, 2014 TABLE OF CONTENTS 1. Introduction...

Lien: Note_de_synth_se_sur_les__tudes_r_alis_es_par_IrisPharma Note de synthèse sur les études réalisées par Iris Pharma Etude n°1 : Test de tolérance locale 1/ But de l’étude Evaluation de l’effet de 3 concentrations de ML7 (0,1%, 0,03% et 0,01%) chez...

COMPTE RENDU DE L'ÉTUDE D'EFFICACITÉ 1. Summary Purpose: The aim of the study was to evaluate the therapeutic potential of topical applied ML7 formulation in a rat model of scopolamine-induced dry eye. Method: Dry eye symptoms were induced in albino Lewis...